Pàgina inicial > Resultats de la cerca: Neurology and Therapy
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 5 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
16 p, 329.8 KB Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective : An Observational Cross-Sectional Study / Meca-Lallana, José E. (Hospital Universitario Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca. Unidad de Neuroinmunología Clínica y Esclerosis Múltiple CSUR. Servicio de Neurología) ; Gómez-Ballesteros, Rocío (Medical Department. Roche Farma) ; Pérez-Miralles, Francisco (Hospital Universitari i Politècnic La Fe (València)) ; Forero, Lucía (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ; Sepúlveda, María (Hospital Clínic i Provincial de Barcelona) ; Calles, Carmen (Hospital Universitario Son Espases. Servicio de Neurología) ; Martínez-Ginés, María L. (Hospital General Universitario Gregorio Marañón) ; González-Suárez, Inés (Hospital Universitario Álvaro Cunqueiro. Servicio de Neurología) ; Boyero, Sabas (Hospital de Cruces (Barakaldo). Servicio de Neurología) ; Romero-Pinel, Lucía (Hospital Universitari de Bellvitge) ; Sempere, Ángel P. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Meca-Lallana, Virginia (Department of Neurology. Hospital Universitario La Princesa) ; Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ; Prefasi, Daniel (Medical Department. Roche Farma) ; Maurino, Jorge (Medical Department. Roche Farma)
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is associated with a reduced health-related quality of life (HRQoL). The purpose of this study was to describe the impact of NMOSD on HRQoL from the patients' perspective and its relationship with other disease factors. [...]
2022 - 10.1007/s40120-022-00356-6
Neurology and Therapy, Vol. 11 Núm. 3 (september 2022) , p. 1101-1116  
Registre complet - Creative Commons
2.
10 p, 277.6 KB Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease : An Observational Study in Spain / Villarejo-Galende, Alberto (Hospital 12 de Octubre (Madrid)) ; García-Arcelay, Elena (Roche Farma) ; Piñol-Ripoll, Gerard (Institut de Recerca Biomèdica de Lleida (IRBLLeida)) ; del Olmo-Rodríguez, Antonio (Hospital Universitari Doctor Peset (València)) ; Viñuela, Félix (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Boada, Mercè (Universitat Internacional de Catalunya) ; Franco-Macías, Emilio (Instituto de Biomedicina de Sevilla) ; de la Peña, Almudena Ibañez (Centro de Investigación de Parkinson) ; Riverol, Mario (Clínica Universidad de Navarra) ; Puig-Pijoan, Albert (Institut Hospital del Mar d'Investigacions Mèdiques) ; Abizanda-Soler, Pedro (Complejo Hospitalario Universitario de Albacete) ; Arroyo, Rafael (Hospital Universitario Quirónsalud) ; Baquero-Toledo, Miquel (Hospital Universitari i Politècnic La Fe (València)) ; Feria-Vilar, Inmaculada (Complejo Hospitalario Universitario de Albacete) ; Balasa, Mircea (Hospital Clínic i Provincial de Barcelona) ; Berbel, Ángel (Hospital Central de la Cruz Roja) ; Rodríguez-Rodríguez, Eloy (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Vieira-Campos, Alba (Hospital Universitario de la Princesa (Madrid)) ; García-Ribas, Guillermo (Hospital Universitario Ramón y Cajal (Madrid)) ; Rodrigo-Herrero, Silvia (Hospital Universitario Juan Ramón Jiménez) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Maurino, Jorge (Roche Farma) ; Universitat Autònoma de Barcelona
Limited information is available on people's experiences of living with Alzheimer's disease (AD) at earlier stages. This study assessed awareness of diagnosis among people with early-stage AD and its impact on different person-centered outcome measures. [...]
2022 - 10.1007/s40120-022-00367-3
Neurology and Therapy, Vol. 11 (june 2022) , p. 1183-1192  
Registre complet - Creative Commons
3.
15 p, 1.4 MB Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial / Bar-Or, Amit (University of Pennsylvania) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Hu, Xixi (Novartis) ; Kropshofer, Harald (Novartis) ; Kukkaro, Petra (Novartis) ; Coello, Neva (Novartis) ; Ludwig, Inga (Novartis) ; Willi, Roman (Novartis) ; Zalesak, Martin (Novartis) ; Ramanathan, Krishnan (Novartis) ; Kieseier, Bernd C. (Novartis) ; Häring, Dieter A. (Novartis) ; Bagger, Morten (Novartis) ; Fox, Edward (University of Texas) ; Universitat Autònoma de Barcelona
Introduction: Several studies have described prognostic value of serum neurofilament light chain (sNfL) at the group level in relapsing multiple sclerosis (RMS) patients. Here, we aimed to explore the temporal association between sNfL and development of subclinical disease activity as assessed by magnetic resonance imaging (MRI) at the group level and evaluate the potential of sNfL as a biomarker for capturing subclinical disease activity in individual RMS patients. [...]
2023 - 10.1007/s40120-022-00427-8
Neurology and Therapy, Vol. 12 Núm. 1 (2023) , p. 303-317  
Registre complet - Creative Commons
4.
18 p, 436.4 KB COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. [...]
2022 - 10.1007/s40120-022-00341-z
Neurology and Therapy, Vol. 11 Núm. 2 (june 2022) , p. 741-758  
Registre complet - Creative Commons
5.
4 p, 243.1 KB Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
2022 - 10.1007/s40120-022-00346-8
Neurology and Therapy, Vol. 11 Núm. 2 (2022) , p. 759-762  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem